Abstract:Objective: Sputum is a source of exfoliated respiratory epithelial cells transformed early in lung carcinogenesis. Malignant cells are hypomethylated and contain less genomic 5-methylcytosine (5mC). Validating a test that recognizes and quantifies aberrantly hypomethylated cells in sputum, we assessed its potential as a screening tool for detecting early-stage non-small cell lung cancer. Methods: Cells extracted from sputum were immunofluorescence labeled with an anti-5-methylcytosine antibody and counterstained with 4',6-diamidino-2-phenylindole (DAPI) delineating global nuclear DNA (gDNA). Via confocal scanning and 3-dimensional image analysis, fluorescence 5mC and DAPI signals were measured in segmented cell nuclei, and a 5mC/DAPI co-distribution map was generated for each imaged cell. Cells were classified as hypomethylated based on 5mC load and 5mC/DAPI co-distribution. The proportion of hypomethylated epithelial cells in the sputum determines whether a patient has lung cancer. Results: A total of 88 subjects were enrolled: 12 healthy subjects; 34 high-risk subjects with benign chronic lung disorders (10 with chronic obstructive pulmonary disease, 24 with idiopathic pulmonary fibrosis), and 43 subjects with non-small cell lung cancer (27 with stage I-II and 16 with stage III-IV). The test identified early-stage non-small cell lung cancer and distinguished it from the high-risk group with 95.8% (95% confidence interval, 78.9-99.9) sensitivity and 41.2% (95% confidence interval, 24.6-59.3) specificity applying only 5mC, 95.8% (95% confidence interval, 78.9-99.9) sensitivity and 26.5% (95% confidence interval, 12.9-44.4) specificity using solely 5mC/DAPI index, and 100% (95% confidence interval, 98.7-100) sensitivity and 26.1% (95% confidence interval, 26.2-27.8) specificity with the combined parameters. Conclusions: We tested and validated a novel, noninvasive, highly sensitive screening test for non-small cell lung cancer. With the use of sputum, our test may impact lung cancer screening, evaluation of pulmonary nodules, and cancer surveillance algorithms.

Nuclear morphology for the detection of alterations in bronchial cells from lung cancer: an attempt to improve sensitivity and specificity

Highly sensitive noninvasive early lung cancer detection using DNA methylation topology in sputum-derived epithelial cells

Utility of cell-free DNA from bronchial washing fluid in diagnosis and genomic determination for radiology-suspected pulmonary nodules

Quantification of Microvascular Dentsity and Cell Nuclear DNA Content in Laryngeal Cancer

[Fluorescence in Situ Hybridization Combined with Cytomorphology for the Detection of Lung Cancer in Bronchial Brushing Specimens].

Complex shape markers can detect alterations in the spatial distribution of cell nuclei in human lung squamous cell carcinoma: a useful tool for automatic analysis?

Descriptive Data on Cancerous Lung Lesions Detected by Auto-Fluorescence Bronchoscope: A Five-Year Study

Development of a nuclear morphometric signature for prostate cancer risk in negative biopsies

A novel technique to assess chromatin texture using pixel optical densitometry in oral squamous cell carcinoma

Cell-free DNA assay for malignancy classification of high-risk lung nodules.

Urinary Biomarkers for Lung Cancer Detection

Cytological Screening Model of Normal Oral Mucosa Exposed to Carcinogens: A Pilot Study

Quantitative analysis of a novel DNA hypermethylation panel using bronchial specimen for lung cancer diagnosis

Subsecond lung cancer detection within a heterogeneous background of normal and benign tissue using single-point Raman spectroscopy

Cytomorphologic analysis of pulmonary neuroendocrine tumors - The physical effect of abrasion and aspiration on cytomorphology

Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids

The Clinical Significance of Detection of P53 Gene Mutation in Patients with Lung Cancer

Cell-free DNA from Bronchoalveolar Lavage Fluid (BALF): a New Liquid Biopsy Medium for Identifying Lung Cancer

Alterations of Serum Inflammatory Biomarkers in the Healthy and Lung Cancer Patients Before and Post Chemotherapy

A comprehensive diagnostic scheme of morphological combined molecular methylation under bronchoscopy